Shubhada S. Jajoo

Assessment of Diagnostic Accuracy of IOTA - ADNEX Model in Detecting the Risk of Malignancy in Ovarian Carcinomas

Cherukuri Srinidhi & Shubhada S. Jajoo · Journal of Pharmaceutical Research International · 2021

Background: Ovarian cancer has become a major public health issue which stood in 10th rank of mortality within India. 2.4 % is the annual new cases of ovarian cancer in overall India. In 2008 it was the seventh leading cause of cancer deaths in women worldwide. 70% of cases are d...

Open access Research Article 10.9734/jpri/2021/v33i64A35721

Comparing the Effectiveness of the Treatment with Neoadjuvant Chemotherapy Followed By Interval Debulking and Primary Debulking Followed By Adjuvant Chemotherapy in Advanced Stage Malignant Ovarian Tumors: A Rural Based Study

Mounika Pottala & Shubhada S. Jajoo · Journal of Pharmaceutical Research International · 2021

Background: Advanced epithelial ovarian cancer is also a poorly prognosed condition with elevated death rate The management of advanced ovarian carcinoma is surgical debulking which is followed by adjuvant chemotherapy. Prognosis reflects primarily on the level of cytoreduction o...

Open access Research Article 10.9734/jpri/2021/v33i37B32037